EyePoint Pharmaceuticals
EYPT
#5228
Rank
S$1.91 B
Marketcap
S$23.11
Share price
0.45%
Change (1 day)
94.69%
Change (1 year)

Market capitalization of EyePoint Pharmaceuticals (EYPT)

Market cap: S$1.91 Billion

As of December 2025 EyePoint Pharmaceuticals has a market cap of S$1.91 Billion. This makes EyePoint Pharmaceuticals the world's 5228th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of EyePoint Pharmaceuticals from 2005 to 2025

End of year Market Cap

Year Marketcap Change
2025S$1.91 B186.41%
2024S$0.66 B-55.19%
2023S$1.49 B832.11%
2022S$0.15 B-71.49%
2021S$0.56 B325.91%
2020S$0.13 B-42.4%
2019S$0.22 B-7.15%
2018S$0.24 B276.69%
2017S$65.37 M-22.71%
2016S$84.58 M-58.13%
2015S$0.20 B26.47%
2014S$0.15 B16.33%
2013S$0.13 B298.31%
2012S$34.47 M15.28%
2011S$29.9 M-75.48%
2010S$0.12 B31.38%
2009S$92.84 M278.18%
2008S$24.54 M2856.2%
2007S$0.83 M-30.52%
2006S$1.19 M-99.66%
2005S$0.34 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of EyePoint Pharmaceuticals was reported to be:

S$1.91 Billion
by Nasdaq info icon info icon
S$1.91 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NRC Health
NRC
S$0.47 B-75.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
S$23.66 M-98.76% Bahamas